Navigation Links
Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
Date:6/14/2008

,16) In patients with thrombosis of unknown origin, PNH may be an underlying cause. (3,12)

Prior to approval of Soliris, there were no therapies specifically available for the treatment of PNH. PNH treatment was limited to symptom management through periodic blood transfusions, non-specific immunosuppressive therapy and, infrequently, bone marrow transplantations -- a procedure that carries considerable mortality risk. (4,17)

About Soliris

Soliris was approved in March 2007 by the U.S. Food and Drug Administration (FDA) as the first treatment for PNH, a rare, debilitating and life-threatening blood disorder defined by hemolysis, or the destruction of red blood cells. In June 2007, the European Commission (EC) also approved the use of Soliris for the treatment of patients with PNH. Soliris is the first therapy approved in Europe for the treatment of PNH and was the first medicinal product to receive EC approval under the EMEA Accelerated Assessment Procedure.

Important Safety Information

Soliris is generally well tolerated. The most frequent adverse events observed in clinical studies were headache, nasopharyngitis (a runny nose), back pain and nausea. Treatment with Soliris should not alter anticoagulant management because the effect of withdrawal of anticoagulant therapy during Soliris treatment has not been established.

The U.S. product label for Soliris also includes a boxed warning: "Soliris increases the risk of meningococcal infections. Vaccinate patients with a meningococcal vaccine at least two weeks prior to receiving the first dose of Soliris; revaccinate according to current medical guidelines for vaccine use. Monitor patients for early signs of meningococcal infections, evaluate immediately if infection is suspected, and treat with antibiotics if necessary." During clinical studies, two out of 196 vaccinated PNH patients treated with Soliris experienced a serious meningococcal infection.

Prior to beginning
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
2. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
3. PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
4. Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
5. Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
6. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
7. Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
8. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
9. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
10. Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer
11. New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 DePuy ... agreement with Radlink, Inc., an emerging global leader ... image guidance with its hip replacement systems. The ... to help improve patient outcomes, increase patient satisfaction ... with the 81st annual meeting of the American ...
(Date:3/26/2015)... CAMBRIDGE, Mass. , March 26, 2015 ... today announced that it will present preclinical ... pipeline at the 2015 American Association for ... April 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia. The ... antibody engineering and nanoliposomal technology platforms, as ...
(Date:3/26/2015)... SANTA CLARA , Kalifornien, 26. März ... neue Veranstaltung Cellworld 2015, die sich speziell ... Bioprozesstechnologien richtet, an. Die zweitägige ... bis 22. September 2015 im Hyatt Regency ... statt. In diesem Forum werden führende ...
Breaking Medicine Technology:DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 2DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 3Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 3Finesse Solutions kündigt Cellworld 2015 an 2
(Date:3/26/2015)... 2015 Building off their success ... education, the Cardiometabolic Risk Summit and ... University are proud to announce a pioneering ... interdisciplinary program , which ultimately grants a ... for physicians, nurse practitioners, physician assistants, registered dietitians, ...
(Date:3/26/2015)... CO (PRWEB) March 26, 2015 Saving ... help where it is most needed but least available. ... therapeutic milk to six clinics in the Benguela province ... severe malnutrition. During a recent visit to their clinics, ... to the mothers and their babies in a nation ...
(Date:3/26/2015)... Capistrano, Calif. (PRWEB) March 26, 2015 ... and repairs, is pleased to be featured on Innovations ... Channel on March 18, 2015. The episode will ... it is live on the Pacific Medical home page ... face life threatening emergencies, it is reassuring to trust ...
(Date:3/26/2015)... Washington DC (PRWEB) March 26, 2015 ... Center for Assessment and Evaluation , has ... technologies that enable institutions, organizations, and corporations to ... to promote successful learning. , Utilizing Questionmark’s ... Testing Services will offer improved delivery of ...
(Date:3/26/2015)... Topsfield, MA (PRWEB) March 26, 2015 ... faced by Skilled Nursing and Assisted Living facilities ... and policy changes during the year. The ... Rehabilitation Therapists, MDS coordinators, CNA’s and the ... the Harmony Healthcare International website ( http://www.harmony-healthcare.com ) ...
Breaking Medicine News(10 mins):Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:Harmony Healthcare International Releases 2015 Post Acute Care Trends Report 2Health News:Harmony Healthcare International Releases 2015 Post Acute Care Trends Report 3
... money to pay for badly needed restorations, are reaching out ... parades, bird-watching lectures, Sunday jazz concerts, brunches with star ... calendar. ,The cemetery tourism fever is catching on. ... aboard the Titanic made many gasp for breath. It looked ...
... of Chaucer were not dwarfs but only short by two ... case with women more or less, a new study by ... ,As part of their study, scientists researched 3000 skeletons ... North East Lincolnshire, and found that the average height of ...
... has found that smokers who have a say in how ... and are more successful. ,The study, which ... of human motivation, was conducted by a team of researchers ... ,The crux of Self-Determination Theory is that a ...
... is of the view that glycerin, a by-product of bio-diesel, ... , ,In his study, Monty Kerley, a professor of ... effectiveness of glycerin as cattle feed. ,Through ... from various breeds to determine if bio-leftovers provide a healthy ...
... four doctors engaged in the illegally removing human kidneys, ... night after police apprehended three middlemen and recovered nine men ... in the city, Lahore police chief Aftab Cheema said. ... raided two private hospitals where the four people underwent surgery. ...
... nation's doctors to work for rural patients. ... in Rohtak, Kalam called upon doctors to make medical facilities ... the zeal to treat at least 20 rural patients a ... taken care of. ,Kalam also told doctors ...
Cached Medicine News:Health News:Cemetery Tourism, the New Catchword in US 2Health News:Our Medieval Ancestors Were More or Less Similar to Us Than Previously Thought 2Health News:Smokers Who Have a Say in How They Quit More Likely to Kick the Habit 2Health News:Study Finds Glycerin to Be a Good Source for Cattle Feed 2
Plus cylinders only trial lens set....
Magnets move the color disks, Protects Disks from fingerprints, Keeps all the disks in one place, Clear glass insures accurate color perception, Makes Color testing fun....
Opti-Free Express multi-purpose disinfecting solution lasting comfort No Rub formula provides triple action protection for your contact lenses....
Grafton Trial Frame...
Medicine Products: